Skip to main content

 home page
 about mesothelioma
 your diagnosis
 treatment of cancer
 caregiving
 health and wellness
 coping with cancer
 finance and planning
 Support and Links
 contact us

 Mesothelioma Aid logo 800-998-9729  
 

Archive for the 'Uncategorized' Category

Pediatric Environmental Health History

Thursday, March 11th, 2010

The physiology and behavior of children makes them more susceptible to the adverse effects of a variety of toxins. In decades past, most issues related to environmental exposure amongst children focused primarily on lead poisoning and second-hand smoke. Off late, the focus has shifted to health effects of other types of exposures as well, for [...]

Hazardous Materials and Chronic Illness

Monday, March 8th, 2010

Work and environmental exposures can lead to or worsen several different types of common diseases, for instance asthma, dermatitis, hepatitis B, carpal tunnel syndrome, and cancer. In a number of cases, the environment or work-related illnesses do not show distinctive clinical presentations: asthma resulting from a cat allergy does not differ from asthma caused by [...]

Measuring Occupational Injuries

Monday, March 1st, 2010

It is difficult to measure the magnitude of occupational illnesses and injuries. The United States Bureau of Labor Statistics (BLS) that provides statistics based on surveys of private companies having more than 11 employees (an underestimate of the real totals), reported 5,488 fatal accidents related to work (3.7 for every 100,000) and around 4.0 million [...]

Off-Label Chemotherapy Use

Friday, February 26th, 2010

Off-label use

An FDA approval implies that the drug can now be used to treat a specific condition when it is administered in the manner described on the drug’s label. Further clinical research may be required to study other potential uses of the drug, for example, to treat a different form of cancer. An off-label use [...]

Drug Development and Approval: Part II

Tuesday, February 23rd, 2010

Orphan drugs
Drugs that are used to treat rare diseases affecting less than 200,000 Americans are referred to as orphan drugs. Since only a small number of patients need these drugs, it may not be possible for the drug’s sponsor to recover the drug development costs. Under the Orphan Drug Act, sponsors are given incentives to [...]

Patient involvement in the approval of new drugs

Friday, February 19th, 2010

Patient can contribute to the drug development and approval process by enrolling themselves in clinical trials. Participating in clinical trials not only contributes to improvements in cancer research and treatment but also allows enrolled patients access to closely monitored care and regular reviews on the status of their disease. The FDA has launched two programs [...]

Some FDA initiatives for improving the process of drug development and approval in the United States.

Friday, February 12th, 2010

1) Accelerated approval

The accelerated approval program run by FDA allows sponsors to request approval on the basis of alternate findings. Also called surrogate endpoints, these are indirect assessments of disease status, for example, a change in lab results or improvements in symptoms related to the disease. These endpoints can also be used to assess [...]

Cancer Cell Metabolism Could Be Key To New Cancer Therapies

Friday, February 12th, 2010

Way back in the 1920s, a German scientist by the name of Otto Warburg reported to the world that cancer cells metabolize sugars in different ways than normal healthy cells. While such a discovery may not seem particularly momentous, this near century-old discovery is continuing to prove its importance by opening the door to a [...]

FDA fast track program

Wednesday, February 10th, 2010

With its fast track drug development programs, the FDA seeks to facilitate the development of new drugs and speed up their approval process. This is especially true in case of drugs that can provide for unmet medical needs pertaining to debilitating or life-threatening diseases such as cancer. An unmet medical need is said to exist [...]

Improving the Approval Process for Foreign Drugs

Monday, February 8th, 2010

The drug regulatory agency in every country has its own specific requirements for drug approval. A drug that has received approval in Japan or Europe cannot be sold in the U.S. market until it gets approved by the Food and Drug Administration. The creation of the International Conference on Harmonization (ICH) was part of the [...]


About Mesothelioma / Mesothelioma Diagnosis / Coping / Staying Healthy / Mesothelioma Blog
Financial Planning / Caregiver's Guide / Patient Support / Contact Us /
Disclaimer and Sponsorship
 





Mesothelioma Aid is a website devoted to life issues for mesothelioma patients and their families, and is sponsored by Jonathan David* of The David Law Firm. The David Law Firm is located in The Woodlands, Texas (Greater Houston Area) and can be reached toll free at 1-800-998-9729 for more information on mesothelioma. Jonathan David is not a medical doctor. The information on these pages is for the education of mesothelioma patients and their families regarding potential medical and legal options. Patients are advised to consult with a medical doctor.

*  Licensed by the Supreme Court  of Texas.

Copyright © The David Law Firm